Home » Topics » Regulatory

Regulatory
RSS

Levaquin sNDA submitted for chronic bacterial prostatitis

Aug. 1, 2002

Eligix CD8-SC Cell Separation System approved in E.U.

Aug. 1, 2002

Manufacturing approval obtained for Onoact

July 31, 2002

E.U. approval for cancer imaging agent Flucis

July 30, 2002

ADVENT trial results support expanded indications for Niaspan

July 30, 2002

New formulation of Rapamune introduced in U.K.

July 26, 2002

Eligard 22.5 mg approved for advanced prostate cancer

July 25, 2002

Serono to develop anastrozole for female infertility

July 25, 2002

Nasonex indication expanded to include children as young as two years

July 23, 2002

Aranesp approved for chemotherapy-induced anemia

July 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...